Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022

SELL
$2.96 - $7.76 $3,256 - $8,536
-1,100 Closed
0 $0
Q4 2021

Jan 14, 2022

BUY
$7.4 - $11.66 $8,140 - $12,826
1,100 New
1,100 $8,000
Q2 2021

Jul 26, 2021

SELL
$8.07 - $12.52 $60,266 - $93,499
-7,468 Closed
0 $0
Q1 2021

May 21, 2021

BUY
$8.57 - $15.79 $64,000 - $117,919
7,468 New
7,468 $74,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $539M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.